INS and Insulin resistance: On the other hand, it would also be of future interest to assess whether DVC GlyT1 inhibition reverses insulin resistance in type 2 diabetic and obese rodents using the hyperinsulinemic–euglycaemic clamp technique to achieve insulin-stimulated conditions.